Skip to main content
PLOS One logoLink to PLOS One
. 2021 Jun 2;16(6):e0252462. doi: 10.1371/journal.pone.0252462

The association between water hardness and xerosis—Results from the Danish Blood Donor Study

Mattias A S Henning 1,*,#, Kristina S Ibler 1,#, Henrik Ullum 2,#, Christian Erikstrup 3,#, Mie T Bruun 4,#, Kristoffer S Burgdorf 2,#, Khoa M Dinh 3,#, Andreas Rigas 2,#, Lise W Thørner 2,#, Ole B Pedersen 5,, Gregor B Jemec 1,
Editor: Feroze Kaliyadan6
PMCID: PMC8171951  PMID: 34077478

Abstract

Background

The pathophysiology of xerosis depends on extrinsic and intrinsic exposures. Residential hard water may constitute such an exposure.

Objectives

To estimate the prevalence of xerosis and to compare water hardness exposure in blood donors with and without xerosis.

Methods

In this retrospective cohort study in 2018–2019, blood donors with self-reported moderately or severely dry skin were compared to blood donors without dry skin. Blood donors with ichthyosis, lichen planus and psoriasis were excluded. Water hardness data was collected from the Geology Survey of Denmark and Greenland.

Results

Overall, 4,748 of 30,721 (15.5%; 95% confidence interval 15.1–15.9%) blood donors had xerosis. After excluding blood donors with ichthyosis, lichen planus and psoriasis, 4,416 blood donors (2,559 females; median age 38.4 years [interquartile range 28.0–49.8]; 700 smokers) remained in this study. Water softer than 12–24 degrees Deutsche härte was associated with decreased probability of xerosis (odds ratio 0.83; 95% confidence interval 0.74–0.94) and water harder than 12–24 degrees Deutsche härte was associated with increased probability of xerosis (odds ratio 1.22; 95% confidence interval 1.03–1.45). The association between water hardness and xerosis remained significant after excluding blood donors with dermatitis.

Conclusions

Water hardness is associated with xerosis independent of other dermatoses.

Introduction

Xerosis, i.e. dry skin, is a common trait in normal skin. In severe forms, xerosis can be a cardinal symptom of several dermatoses, including atopic dermatitis (AD), ichthyosis and psoriasis [1]. Xerosis manifests with focal or generalized dry, rough, and scaly skin, often accompanied by pruritus and fissures and it can lead to reduced quality of life [14]. The prevalence of xerosis ranges from 30 to 60% in adults and elderly individuals aged 70 years and above in Western Europe [2, 3, 5, 6]. In addition to age, common risk factors include dermatitis, history of atopy, female sex, smoking and previous chemotherapy [2, 3, 5, 6]. The pathophysiology of xerosis depends on extrinsic and intrinsic exposures that induce alterations in stratum corneum such as defective keratinization and lipid cement abnormalities, implying that xerosis may be a marker of e.g. irritant contact dermatitis [1]. Water with high calcium carbonate (CaCO3) concentration, i.e. hard water constitutes a harmful and irritative exposure that can disturb the skin barrier [710]. Research has suggested that hard water is associated with the development and worsening of AD in children and teenagers [710]. Tap water in Denmark comes from deep laying natural reservoirs and requires only mild modifications before reaching the households [11]. Therefore, it reflects the composition of the ground sediment, which in east Denmark primarily consists of limestone and chalk and in west Denmark primarily consist of clay and sand [11]. Thus, there are regional ground sediment differences that influence water CaCO3 concentration and hardness [8]. Whether hard water is associated with xerosis remains unexplored. Therefore, the aims of the current study are to estimate the prevalence of xerosis in a large cohort of Danish blood donors and to compare the exposure water hardness, in blood donors with and without xerosis.

Materials and methods

This retrospective cohort study is based on data collected from the Danish Blood Donor Study (DBDS) [12]. Danish blood donors aged 18 to 67 years, who completed the study questionnaire between June 2018 and March 2019 and who provided a written informed consent were eligible for study inclusion. A detailed description of the DBDS is published elsewhere [12].

Exposure

Water hardness was based on the average level of water hardness across all water works within each study participant’s home municipality. Data on water hardness was collected from the Geology Survey for Denmark and Greenland and water hardness was treated as an ordinal variable ranking ascendingly as follows: <4 (very soft), 4≤8 (soft), 8≤12 (soft to medium), 12≤18 (medium to hard), 18≤24 (hard), 24≤30 (very hard), and >30 (extremely hard) degrees Deutsche Härte (°dH) [8, 13]. However, as some groups had none or few study participants, they were collapsed into the three groups <12, 12–24, and >24°dH. The measuring unit of water hardness is °dH [13]. 1°dH equals 10 mg dissolved CaCO3 per liter and the mean level of water hardness in Denmark is 12–24°dH [13]. Danish citizens born after 1967 are assigned a unique Civil Personal Register (CPR) Number [14]. This ensures efficient linking of different databases and complete and accurate registration of data, including home addresses and hospital diagnoses, which were used in this study.

Participants with xerosis

Blood donors were asked to answer the xerosis-screening question ‘Have you had dry skin?’ Those who answered ‘Yes, moderately’ or ‘Yes, severely’ were classified as cases in Xerosis 1. Respondents with ichthyosis, lichen planus, and psoriasis were excluded from Xerosis 1. Blood donors included in Xerosis 1 who did not have a history of atopic dermatitis, seborrheic dermatitis, diaper dermatitis, allergic contact dermatitis, irritant contact dermatitis, unspecified contact dermatitis, exfoliative dermatitis or hand eczema were additionally included in the subgroup Xerosis 2.

Participants without xerosis (controls)

Blood donors who answered ‘No’ in the aforementioned xerosis-screening question and who did not have ichthyosis, lichen planus, psoriasis, or an International Classification of Disease (ICD)-10th edition diagnosis for xerosis were defined as Control 1. Blood donors from Control 1 who did not have dermatitis were additionally included in the subgroup Control 2. International Classification of Disease-10th are disease diagnoses assigned to all patients attending in- and outpatient clinics in Denmark and the data in this study covered the period 1994 to 2018.

Dermatitis, ichthyosis, lichen planus and psoriasis

Dermatitis was defined as having ICD-10th edition primary diagnoses, secondary diagnoses, or underlying medical condition diagnoses for dermatitis (S1 Table) or as having self-reported dermatitis in the study questionnaire. Self-reported dermatitis was defined as having answered ‘Yes, moderately’ or ‘Yes, severely’ to the items ‘Have you had an itchy rash on your hands?’ or ‘Have you had eczema?’ or having answered ‘Yes’ to the items ‘Have you had hand eczema?’ or ‘Have you had childhood eczema?’. Ichthyosis, lichen planus, and psoriasis were defined as having ICD-10th edition primary diagnoses, secondary diagnoses, or underlying medical condition diagnoses for ichthyosis, lichen planus, or psoriasis (S1 Table). Self-reported psoriasis was based on the diagnostic algorithm by Dominguez et al. [15].

Covariables

Age, sex, and smoking were collected from the study questionnaire. Age was coded as a continuous variable. Sex was coded as a dichotomous variable indicating female or male sex. Smoking was coded as a dichotomous variable indicating presence or absence of habitual smoking. Socioeconomic status (SES) was coded as a nominal variable with the following five categories: working, unemployed, studying, on public support, and pensioner. Working were individuals who were employed, self-employed, or individuals who assisted their employed or self-employed spouse. Unemployed were individuals without employment for at least 6 months in the past 12 months. On public support were individuals who collected sickness benefits, paid leave benefits, or education allowances. Studying were individuals who were students. Pensioner were individuals who were receiving a pension after retirement. Data on SES covered the period 1991 to 2018 and it was collected from Statistics Denmark. Blood donors that had completed the study questionnaire between December 1, 2018 and February 29, 2019 were defined as inclusions in the cold season and it was coded as a dichotomous variable.

Bias

The inclusion in the DBDS was based on convenience sampling from the general population. However, inclusion was not based on presence of any disease and therefor, this was a non-differential bias. Additionally, the inclusion was conducted by blood bank nurses who did not conduct any DBDS related research, which further minimized the effect of this non-differential bias. The risk of confounding was generally low as we included blood donors without severe disease or medication that could lead to xerosis. We also excluded dermatitis, ichthyosis, lichen planus and psoriasis, which are known to be characterized by xerosis. In addition, we included possible confounders in the study questionnaire to enable adjusting for these variables in the statistical analyses. To minimize the impact of recall bias, we used non-self-reported variables or to a high degree, simple self-reported variables that were unlikely to be affected by recall bias. To isolate xerosis, concurrent disease that can cause xerosis was excluded. This was done by including blood donors who have few systemic diseases or who are under chronic medication that can cause xerosis. Additionally, we excluded anyone with dermatoses that are known to manifest with xerosis, such as ichthyosis, lichen planus, psoriasis and dermatitis. In the clinical context, the transition from dermatitis to xerosis is not always clear. Conversely, mild dermatitis can manifest only with xerosis. Therefore, to avoid eliminating potential cases with xerosis we chose to first define a study population with dermatitis (i.e. xerosis 1) and then also define a homogenous population with xerosis without moderate or severe dermatitis (i.e. xerosis 2).

Statistics

Histograms and qq-plots determined normality. No outliers were detected. In descriptive statistics, normally distributed continuous variables were presented with mean and standard deviation, non-normally distributed continuous variables were presented with median and interquartile range, and categorical variables were presented with frequency distribution and percentages. Differences between xerosis cases and controls were assessed using independent samples two-sided Student t-test for normally distributed continuous variables; Mann-Whitney U for non-normally distributed continuous variables, ordinal variables and nominal variables; and Chi-square or Fisher’s exact test for dichotomous variables. Multinominal unadjusted crude and adjusted regression was conducted with xerosis as outcome; water hardness as exposure; and sex, age, smoking, SES and cold season as potential confounders. All exposure and potential confounders were between-subject variables. Model selection was based on Akaike Information Criterion, which indicated that the optimal model included all potential confounders. Interaction between age and sex was determined in a nominal regression model. Observations with missing data were excluded from the statistical analyses. Benjamini-Hochberg procedure for multiple testing was applied with a false discovery rate of 0.05%. Effect sizes were reported as odds ratio (OR) with 95% confidence interval (CI). Statistics was calculated using R, version 3.6.3, and p-values below 0.05 were considered statistically significant [1621]. The assumptions of nominal regression were met. The statistical analysis did not account for clustering by municipality.

Ethics statement

The Central Danish and Zealand Regional Committees on Health Research Ethics approved the study (M-20090237 and SJ-740, respectively) and the Danish Data Protection Agency approved the study (P-2019-99). Procedures were in accordance with the Helsinki Declaration of 1975, as revised in 1983. Written informed consent was obtained from all study participants prior to study inclusion.

Results

Fig 1 shows a flow chart of how the study population was defined. Altogether 4,748 of 30,721 blood donors reported having moderate to severe xerosis, which equals a prevalence of 15.5% (95% CI 15.1–15.9%). After excluding blood donors with ichthyosis, lichen planus and psoriasis, 4,416 blood donors remained in this study.

Fig 1. Flowchart depicting the process of inclusions and exclusions.

Fig 1

DBDS, Danish Blood Donor Study; ICD-10, International Classification of Disease-10; n, Study population.

There were significant differences between blood donors in xerosis 1 versus control 1 and in xerosis 2 versus control 2 for age, smoking, SES, water hardness, and inclusion in the cold season (Table 1).

Table 1. Demographics of blood donors with xerosis and controls.

Xerosis 1, n = 4,416 Control 1, n = 9,546 P-valuea Xerosis 2, n = 3,791 Controls 2, n = 9,389 P-valuea
Sex
    Male, n (%) 1,857 (42.1) 5,586 (58.5) 1,600 (42.2) 5,535 (59.0)
    Female, n (%) 2,559 (57.9) 3,960 (41.5) 2,191 (57.8) 3,854 (41.0)
    Missing, n (%) 0 (0) 0 (0) 0 (0) 0 (0)
Age, years <0.001 <0.001
    Total, median (IQR) 38.4 (28.0–49.8) 44.4 (31.0–53.8) 38.4 (27.7–49.7) 44.4 (31.0–53.9)
    Male, median (IQR) 38.9 (29.4–50.3) 44.9 (32.2–54.0) 39.0 (29.4–50.1) 44.9 (32.3–54.0)
    Female, median (IQR) 38.0 (26.7–49.0) 43.8 (29.0–53.6) 37.8 (26.4–49.1) 43.7 (29.0–53.7)
    Missing, n (%) 0 (0) 0 (0) 0 (0) 0 (0)
Smoking, n (%) 700 (15.9) 1,247 (13.1) <0.001 3,188 (84.1) 1,228 (13.1) <0.001
Non-smoking, n (%) 3,712 (84.0) 8,288 (86.8) 601 (15.8) 8,150 (86.8)
    Missing, n (%) 4 (0.1) 11 (0.1) 2 (0.1) 11 (0.1)
Socioeconomic status <0.001 <0.001
Working, n (%) 3,351 (75.9) 7,787 (81.6) 2,868 (75.7) 7,665 (81.6)
    Unemployed, n (%) 92 (2.1) 157 (1.6) 79 (2.1) 154 (1.6)
    Studying, n (%) 102 (2.3) 127 (1.3) 83 (2.2) 124 (1.3)
    On public support, n (%) 818 (1.2) 1,317 (13.8) 717 (18.9) 1,291 (13.8)
    Pensioner, n (%) 53 (1.2) 158 (1.7) 44 (1.2) 153 (1.6)
    Missing, n (%) 0 (0) 0 (0) 0 (0) 2 (0.0)
Water hardness, °dH <0.001 <0.001
    <12, n (%) 439 (9.9) 1,166 (12.2) 387 (10.2) 1,148 (12.2)
    12–24, n (%) 3,725 (84.4) 7,986 (83.7) 3,189 (84.1) 7,854 (83.7)
    >24, n (%) 252 (5.7) 394 (4.1) 215 (5.7) 387 (4.1)
    Missing, n (%) 0 (0) 0 (0) 0 (0) 0 (0)
Water hardness, °dH <0.001 <0.001
    <4, n (%) 0 (0) 0 (0) 0 (0) 0 (0)
    4 ≤8, n (%) 73 (1.7) 152 (1.6) 63 (1.7) 149 (1.6)
    8≤12, n (%) 366 (8.3) 1,014 (10.6) 324 (8.6) 999 (10.6)
    12≤18, n (%) 2,432 (55.1) 5,562 (58.3) 2,073 (54.7) 5,477 (58.3)
    18≤24, n (%) 1,293 (29.3) 2,424 (25.4) 1,116 (29.4) 2,377 (25.3)
    24≤30, n (%) 74 (1.7) 138 (1.5) 64 (1.7) 136 (1.5)
    >30, n (%) 178 (4.0) 256 (2.7) 151 (4.0) 251 (2.7)
    Missing, n 0 (0) 0 (0) 0 (0) 0 (0)
Cold season, n (%) 1,384 (31.3) 7,366 (22.8) <0.001 1,215 (32.0) 2,135 (22.7) <0.001
Non-cold season, n (%) 3,032 (68.7) 2,180 (77.2) 2,576 (68.0) 7,254 (77.3)
    Missing, n (%) 0 (0) 0 (0) 0 (0) 0 (0)

dH, Deutsche Härte; IQR, Interquartile Range; n, Study Population.

aDifference between Xerosis and Controls assessed by Mann-Whitney U or Chi-square test.

The unadjusted crude and adjusted multivariable nominal regression models showed statistically significant associations between water softer and harder than the reference group of 12–24°dH and a lower and a higher probability of xerosis, respectively (Tables 2, 3 and S2, S1 Figs).

Table 2. Unadjusted nominal regression model with xerosis as outcome.

Xerosis 1 versus Control 1 Xerosis 2 versus Control 2
Est SE OR (95% CI) P-value Est SE OR (95% CI) P-value
Water hardness <12°dH -0.21 0.02 0.81 (0.72–0.91) <0.001 -0.19 0.06 0.83 (0.73–0.94) 0.003
Water hardness 12–24°dH Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref.
Water hardness >24°dH 0.32 0.08 1.37 (1.16–1.61) <0.001 0.31 0.09 1.37 (1.15–1.62) <0.001
Age -0.02 0.001 0.98 (0.98–0.98) <0.001 -0.02 0.001 0.98 (0.98–0.98) <0.001
Female Sex 0.66 0.04 1.94 (1.81–2.09) <0.001 0.68 0.04 1.97 (1.82–2.12) <0.001
Habitual smoking 0.23 0.05 1.25 (1.13–1.39) <0.001 0.22 0.05 1.25 (1.13–1.39) <0.001
Socioeconomic status 0.10 0.02 1.11 (1.08–1.14) <0.001 0.11 0.02 1.12 (1.08–1.15) <0.001
Cold season 0.43 0.04 1.54 (1.42–1.67) <0.001 0.47 0.04 1.60 (1.47–1.74) <0.001

CI, Confidence interval; °dH, Degree Deutsche Härte; Est, Estimate; OR, Odds ratio; SE, Standard error.

Table 3. Adjusted multinominal regression model with xerosis as outcome.

Xerosis 1 versus Control 1a Xerosis 2 versus Control 2a
Est SE OR (95% CI) p-value Est SE OR (95% CI) p-value
Water hardness <12°dH -0.18 0.06 0.83 (0.74–0.94) 0.003b -0.15 0.06 0.86 (0.76–0.98) 0.02b
Water hardness 12–24°dH Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref.
Water hardness >24°dH 0.20 0.09 1.22 (1.03–1.45) 0.02b 0.19 0.09 1.21 (1.02–1.45) 0.03b
Age -0.02 0.002 0.98 (0.98–0.98) <0.001b -0.02 0.002 0.98 (0.98–0.98) <0.001b
Female Sex 0.63 0.04 1.88 (1.75–2.02) <0.001b 0.64 0.04 1.90 (1.75–2.05) <0.001b
Habitual smoking 0.14 0.05 1.16 (1.05–1.29) 0.004b 0.15 0.06 1.16 (1.04–1.29) 0.007b
Socioeconomic status -0.02 0.02 0.98 (0.95–1.01) 0.22 -0.02 0.02 0.98 (0.95–1.02) 0.33
Cold season 0.41 0.04 1.50 (1.39–1.63) <0.001b 0.45 0.04 1.56 (1.44–1.70) <0.001b

CI, Confidence interval; °dH, Degree Deutsche Härte; Est, Estimate; OR, Odds ratio; SE, Standard error.

aAdjusted for age, sex, smoking, socioeconomic status, and cold season.

bSignificant after Benjamini–Hochberg correction with a false discovery rate of 0.05%.

The results from the interaction analysis showed no significant interaction between age and sex (S3 Table).

Discussion

In this retrospective cohort study, we determined the self-reported prevalence of xerosis in Danish blood donors. We also demonstrated that water hardness was associated with xerosis independent of co-morbidities and potential confounders such as age, sex, smoking, SES and cold season. The prevalence of self-reported xerosis in blood donors was lower than the prevalence of xerosis in other studies of adult workers and elderly individuals aged 70 to 80 years [2, 3, 5, 6]. The reason for the differences in prevalence is probably methodological, as previous studies have used clinically diagnosed xerosis whereas our study is based on self-reported data and ICD-10th data [2, 3, 6]. Additional explanations may include the healthy donor effect, varying presence of xerosis risk factors, and age differences in different studies [2, 3, 5, 22]. The healthy donor effect, i.e. the lower proportion of morbidity in blood donors than in the background population, likely reduced the prevalence of xerosis in the study population as compared to the prevalence of xerosis in the Danish population [22]. This is because the exclusion criteria for blood donation precluded individuals with many xerosis risk factors, including severe disease, systemic medications, and age above 67 years, from donating blood [23].

Blood donors living in areas with water softer than 12–24°dH were less likely of having xerosis, while blood donors living in areas with water harder than 12–24°dH were more likely of having xerosis independent of dermatoses where xerosis is an essential symptom, including ichthyosis, lichen planus, and psoriasis. These associations remained significant after excluding blood donors with dermatitis. These results lead us to speculate that hard water is a clinically relevant irritant and not only a specific predisposing factor for AD.

In the literature, a non-randomized interventional study showed that hard water with 11 grain CaCO3 induced erythema and dry skin in 36 adult women compared to soft water with zero grain CaCO3 [24]. Likewise, another non-randomized interventional study found that water without CaCO3 reduced skin dryness, pruritus, scaling, and transepidermal water loss (TEWL) in 8 patients with AD after 28 days compared to normal tap water [25]. Several epidemiological studies on thousands of children between 4 and 12 years have found evidence for associations between water hardness and development of AD [7, 9, 10]. However, a randomized blinded controlled trial of 336 participants with AD, aged 6 months to 16 years, reported no additional effect from the combination of tap water softener and usual eczema care (i.e. topical corticosteroids and emollients) compared to monotherapy of the latter [26].

Physiological explanations for the observed association between water hardness and xerosis may include allergic and irritative mechanisms [24, 25, 27]. Hard water with high calcium content decrease wash product solubility and thus increase depositions of soap residuals on the skin [25, 27]. Furthermore, calcium reduces the lathering of soaps, which means that there is a risk for excessive soap consumption and compensatory protracted skin scrubbing [25]. This can lead to skin barrier damage and irritative and allergic dermatitis [24, 25].

Implications

The findings of the current study imply that hard water is a valid public concern, as it constitutes an inevitable exposure for many people. Prevention strategies that minimize contact with hard water and soaps may play an important role in primary prevention against xerosis and dermatitis, and especially in those with preexisting susceptible skin [28]. Additional primary and secondary preventative initiatives for those living in areas with hard residential water may include information campaigns and adequate use of moisturizing products, which can control dry skin and inhibit development of dermatitis [29, 30]. Forums for conveying relevant strategies to targeted populations include patient eczema schools and public health campaigns.

Xerosis is a risk factor and a symptom of irritant contact dermatitis [31, 32]. Irritant contact dermatitis develops second to repeated exposure to irritants, including soaps and water [33]. Irritant contact dermatitis is the most common occupational skin disease, and it can be debilitating for affected individuals and lead to sick leave, change of profession, and ultimately unemployment [3436]. Therefore, to avoid occupational irritant contact dermatitis, career counselors should be aware of this observed association between water hardness and xerosis when advising young people with susceptible skin on future professions. In addition, the described association between water hardness and xerosis raises the question whether water softeners can reduce the risk of xerosis. The potential of water softening for the prevention of AD has been studied before, which reported no additional treatment effect from softener when compared to conventional eczema care [26]. To the best of the authors’ knowledge, the effect of water softener has never been studied using xerosis as a primary endpoint.

Strengths and limitations

Methodological strengths of the current study, in which we have determined the prevalence of self-reported xerosis and compared individuals with and without xerosis, include a large study population and access to important variables. This allows for statistical adjustments that reduce the risk of confounding. Furthermore, the study participants were blood donors with low risk of diseases or medications that may cause secondary xerosis. A further benefit is that the observational timespan is significantly wider than that of a physician examination, thus being able to identify a basic character of the skin more accurately. Self-reported xerosis also has limitations. Report bias may limit the validity of self-reported variables and outcomes. This is exemplified by the fact that in previous studies, xerosis is known to increase with advancing age [2, 3]. However, in the current study, blood donors with xerosis had a lower median age than healthy controls. This may be attributed to that older blood donors have learned to live with xerosis and therefore, do not consider xerosis a symptom, and thus do not report it as such in the study questionnaire, while younger blood donors consider xerosis a symptom and therefore report it in the study questionnaire. In addition to the gradient of water becoming harder from west to east of Denmark, there may be other geographical gradients from west to east of Denmark that can confound the observed association between water hardness and xerosis [8]. An example of such a gradient can be population density. Western part of Jutland has lower population density and the softest residential water in Denmark, while eastern part of Jutland, Funen, and Zealand are both more densely populated and have the hardest residential water in Denmark [8, 37]. As living in urban areas is a risk factor for developing dermatitis, it may confound the observed association between hard water and xerosis [38, 39]. This is further substantiated by other studies that have found that a rural upbringing may protect against dermatitis [38, 40]. Potential explanations for the risk implicated in living in urban versus rural areas may include differences in family size; exposure to outside air pollution, tobacco smoke, and domestic animals; maternal age; and indoor versus outdoor lifestyles [38, 39]. However, we statistically adjusted for one of these explanatory factors (i.e. habitual smoking) in the nominal regression model. We did not have access to data on the other mentioned potential explanations. However, to account for potential residual confounding, we included SES in the nominal regression because SES is different in urban versus rural areas [41]. The results showed that SES was not statistically significantly associated with xerosis and nor did inclusion of SES as a confounder change the OR between water hardness and xerosis. Thus, there was no significant confounding from SES. Furthermore, previous research has shown evidence for association between hard water and dermatitis [7, 9, 10]. Water pH depends on the dissolvents in water and research has shown that it can influence the risk of dermatitis [42]. As dissolved CaCO3 determines the water hardness and also strongly influences water pH, it can be speculated that water pH is an intermediate step in an indirect pathway between water hardness and xerosis and as such, not fulfills the criteria for being a confounder. Therefore, adjusting for pH may lead to over adjustment bias that incorrectly underestimates the overall effect of hard water on xerosis. Another limitation is the study design, which allows us to conclude on association between water hardness and xerosis independent of potential confounders, but it impairs inferring on causality. Extrapolation may also be limited owing to the risk of selection bias from only including blood donors who generally are healthier than the background population [22]. Another potential bias is that some study participants may have been working in areas other than their home municipality, and thereby been exposed to different levels of water hardness. However, the level of water hardness is generally the same across several neighboring municipalities, which means that working in neighboring municipalities would not necessarily change the water hardness exposure. This is further substantiated by a study of almost 29,000 Danes that showed that the mean distance of commute to work or education was 14.6 km, which implies that many work in their home or neighboring municipalities [43]. Additionally, many jobs do not include ‘wet work’. Therefore, we argue that the home municipality is the best approximation for routine water exposure.

In conclusion, we find a consistent association between self-reported xerosis and increasing water hardness. This association is independent of dermatitis, ichthyosis, lichen planus and psoriasis. This implies that hard water can constitute a concern to the public as it represents an inevitable exposure to a considerable proportion of the population. Future studies that seek to reproduce these findings in diverse study populations are warranted. Furthermore, there is a need to explore the causative mechanism of the observed association between water hardness and xerosis.

Supporting information

S1 Fig. Forest plot of adjusted multinominal regression.

(TIFF)

S1 Table. ICD-10th diagnoses used to define xerosis, dermatitis, ichthyosis, lichen planus and psoriasis.

(DOCX)

S2 Table. Adjusted multivariable nominal regression with xerosis as outcome.

(DOCX)

S3 Table. Multivariable nominal regression with xerosis as outcome and interaction for age and sex.

(DOCX)

Acknowledgments

Thomas Folkmann Hansen is greatly acknowledged for his work in DBDS.

Data Availability

Data cannot be shared publicly because of legal restrictions imposed by the Danish Act on Processing of Personal Data. Data are available from the Videncenter for Dataanmeldelser (contact via webpage: https://www.regionh.dk/til-fagfolk/Forskning-og-innovation/jura-og-data/Videnscenterfordataanmeldelser/Sider/default.aspx; telephone number +45 29 35 67 99; and e-mail: cru-fp-vfd@regionh.dk) for researchers who meet the criteria for access to confidential data.

Funding Statement

MASH was provided a grant for research from Leo Foundation, Denmark (https://leo-foundation.org/en/). Grant number LF 18002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Pons-Guiraud A. Dry skin in dermatology: a complex physiopathology. Journal of the European Academy of Dermatology and Venereology: JEADV. 2007;21 Suppl 2:1–4. Epub 2007/10/11. 10.1111/j.1468-3083.2007.02379.x . [DOI] [PubMed] [Google Scholar]
  • 2.Augustin M, Kirsten N, Korber A, Wilsmann-Theis D, Itschert G, Staubach-Renz P, et al. Prevalence, predictors and comorbidity of dry skin in the general population. Journal of the European Academy of Dermatology and Venereology: JEADV. 2019;33(1):147–50. Epub 2018/06/29. 10.1111/jdv.15157 . [DOI] [PubMed] [Google Scholar]
  • 3.Mekic S, Jacobs LC, Gunn DA, Mayes AE, Ikram MA, Pardo LM, et al. Prevalence and determinants for xerosis cutis in the middle-aged and elderly population: A cross-sectional study. Journal of the American Academy of Dermatology. 2019;81(4):963–9.e2. Epub 2018/12/27. 10.1016/j.jaad.2018.12.038 . [DOI] [PubMed] [Google Scholar]
  • 4.Kini SP, DeLong LK, Veledar E, McKenzie-Brown AM, Schaufele M, Chen SC. The impact of pruritus on quality of life: the skin equivalent of pain. Archives of dermatology. 2011;147(10):1153–6. Epub 2011/06/18. 10.1001/archdermatol.2011.178 . [DOI] [PubMed] [Google Scholar]
  • 5.Lichterfeld A, Lahmann N, Blume-Peytavi U, Kottner J. Dry skin in nursing care receivers: A multi-centre cross-sectional prevalence study in hospitals and nursing homes. Int J Nurs Stud. 2016;56:37–44. Epub 2016/01/27. 10.1016/j.ijnurstu.2016.01.003 . [DOI] [PubMed] [Google Scholar]
  • 6.Paul C, Maumus-Robert S, Mazereeuw-Hautier J, Guyen CN, Saudez X, Schmitt AM. Prevalence and risk factors for xerosis in the elderly: a cross-sectional epidemiological study in primary care. Dermatology. 2011;223(3):260–5. Epub 2011/11/23. 10.1159/000334631 . [DOI] [PubMed] [Google Scholar]
  • 7.Arnedo-Pena A, Bellido-Blasco J, Puig-Barbera J, Artero-Civera A, Campos-Cruanes JB, Pac-Sa MR, et al. [Domestic water hardness and prevalence of atopic eczema in Castellon (Spain) school children]. Salud Publica Mex. 2007;49(4):295–301. Epub 2007/08/22. 10.1590/s0036-36342007000400009 . [DOI] [PubMed] [Google Scholar]
  • 8.Engebretsen KA, Bager P, Wohlfahrt J, Skov L, Zachariae C, Nybo Andersen AM, et al. Prevalence of atopic dermatitis in infants by domestic water hardness and season of birth: Cohort study. The Journal of allergy and clinical immunology. 2017;139(5):1568–74.e1. Epub 2016/12/27. 10.1016/j.jaci.2016.11.021 . [DOI] [PubMed] [Google Scholar]
  • 9.McNally NJ, Williams HC, Phillips DR, Smallman-Raynor M, Lewis S, Venn A, et al. Atopic eczema and domestic water hardness. Lancet. 1998;352(9127):527–31. Epub 1998/08/26. 10.1016/s0140-6736(98)01402-0 . [DOI] [PubMed] [Google Scholar]
  • 10.Miyake Y, Yokoyama T, Yura A, Iki M, Shimizu T. Ecological association of water hardness with prevalence of childhood atopic dermatitis in a Japanese urban area. Environmental research. 2004;94(1):33–7. Epub 2003/12/04. 10.1016/s0013-9351(03)00068-9 . [DOI] [PubMed] [Google Scholar]
  • 11.Jørgensen L, Stockmarr J. Groundwater monitoring in Denmark: Characteristics, perspectives and comparison with other countries. Hydrogeology Journal—HYDROGEOL J. 2009;17:827–42. 10.1007/s10040-008-0398-7 [DOI] [Google Scholar]
  • 12.Burgdorf KS, Felsted N, Mikkelsen S, Nielsen MH, Thørner LW, Pedersen OB, et al. Digital questionnaire platform in the Danish Blood Donor Study. Comput Methods Programs Biomed. 2016;135:101–4. Epub 2016/09/03. 10.1016/j.cmpb.2016.07.023 . [DOI] [PubMed] [Google Scholar]
  • 13.Rigas AS, Ejsing BH, Sorensen E, Pedersen OB, Hjalgrim H, Erikstrup C, et al. Calcium in drinking water: effect on iron stores in Danish blood donors-results from the Danish Blood Donor Study. Transfusion. 2018;58(6):1468–73. Epub 2018/03/27. 10.1111/trf.14600 . [DOI] [PubMed] [Google Scholar]
  • 14.Schmidt M, Schmidt SAJ, Adelborg K, Sundbøll J, Laugesen K, Ehrenstein V, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–91. Epub 2019/08/03. 10.2147/CLEP.S179083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Dominguez PL, Assarpour A, Kuo H, Holt EW, Tyler S, Qureshi AA. Development and pilot-testing of a psoriasis screening tool. The British journal of dermatology. 2009;161(4):778–84. Epub 2009/07/02. 10.1111/j.1365-2133.2009.09247.x . [DOI] [PubMed] [Google Scholar]
  • 16.Wickham Hadley, Miller E. haven:Import and Export ‘SPSS’, ‘Stata’ and ‘SAS’ Files. 2019. [Google Scholar]
  • 17.Hadley Wickham MA, Jennifer Bryan, Chang Winston, McGowan Lucy D’Agostino, François Romain, s Garrett, et al. Welcome to the {tidyverse}. Journal of Open Source Software. 2019;4(43):1686. 10.21105/joss.01686 [DOI] [Google Scholar]
  • 18.Hadley Wickham RF, Lionel Henry, Kirill Müller. dplyr: A Grammar of Data Manipulation. 2020. [Google Scholar]
  • 19.Matt Dowle AS. data.table: Extension of ‘data.frame’.
  • 20.Team RC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2020. [Google Scholar]
  • 21.Venables W. N., Riplsey BD. Modern Applied Statistics with S. Fourth ed: Springer; 2002. [Google Scholar]
  • 22.Atsma F, Veldhuizen I, Verbeek A, de Kort W, de Vegt F. Healthy donor effect: its magnitude in health research among blood donors. Transfusion. 2011;51(8):1820–8. Epub 2011/02/24. 10.1111/j.1537-2995.2010.03055.x . [DOI] [PubMed] [Google Scholar]
  • 23.https://bloddonor.dk/tapning-hvor-og-hvordan/tappepauser/liste-tappepauser/.
  • 24.Warren R, Ertel KD, Bartolo RG, Levine MJ, Bryant PB, Wong LF. The influence of hard water (calcium) and surfactants on irritant contact dermatitis. Contact Dermatitis. 1996;35(6):337–43. Epub 1996/12/01. 10.1111/j.1600-0536.1996.tb02414.x . [DOI] [PubMed] [Google Scholar]
  • 25.Tanaka A, Matsuda A, Jung K, Jang H, Ahn G, Ishizaka S, et al. Ultra-pure soft water ameliorates atopic skin disease by preventing metallic soap deposition in NC/Tnd mice and reduces skin dryness in humans. Acta dermato-venereologica. 2015;95(7):787–91. Epub 2015/03/06. 10.2340/00015555-2083 . [DOI] [PubMed] [Google Scholar]
  • 26.Thomas KS, Dean T, O’Leary C, Sach TH, Koller K, Frost A, et al. A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in children. PLoS Med. 2011;8(2):e1000395. Epub 2011/03/02. 10.1371/journal.pmed.1000395 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Danby SG, Brown K, Wigley AM, Chittock J, Pyae PK, Flohr C, et al. The Effect of Water Hardness on Surfactant Deposition after Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects. The Journal of investigative dermatology. 2018;138(1):68–77. Epub 2017/09/21. 10.1016/j.jid.2017.08.037 . [DOI] [PubMed] [Google Scholar]
  • 28.Danby SG, Al-Enezi T, Sultan A, Chittock J, Kennedy K, Cork MJ. The effect of aqueous cream BP on the skin barrier in volunteers with a previous history of atopic dermatitis. The British journal of dermatology. 2011;165(2):329–34. Epub 2011/05/14. 10.1111/j.1365-2133.2011.10395.x . [DOI] [PubMed] [Google Scholar]
  • 29.Nowak DA, Yeung J. Diagnosis and treatment of pruritus. Can Fam Physician. 2017;63(12):918–24. Epub 2017/12/15. [PMC free article] [PubMed] [Google Scholar]
  • 30.Purnamawati S, Indrastuti N, Danarti R, Saefudin T. The Role of Moisturizers in Addressing Various Kinds of Dermatitis: A Review. Clin Med Res. 2017;15(3–4):75–87. Epub 2017/12/13. 10.3121/cmr.2017.1363 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Seyfarth F, Schliemann S, Antonov D, Elsner P. Dry skin, barrier function, and irritant contact dermatitis in the elderly. Clinics in dermatology. 2011;29(1):31–6. Epub 2010/12/15. 10.1016/j.clindermatol.2010.07.004 . [DOI] [PubMed] [Google Scholar]
  • 32.Owen JL, Vakharia PP, Silverberg JI. The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis. American journal of clinical dermatology. 2018;19(3):293–302. Epub 2018/01/07. 10.1007/s40257-017-0340-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Diepgen TL. Occupational skin diseases. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG. 2012;10(5):297–313; quiz 4–5. Epub 2012/03/30. 10.1111/j.1610-0387.2012.07890.x . [DOI] [PubMed] [Google Scholar]
  • 34.Diepgen TL, Coenraads PJ. The epidemiology of occupational contact dermatitis. International archives of occupational and environmental health. 1999;72(8):496–506. Epub 1999/12/11. 10.1007/s004200050407 . [DOI] [PubMed] [Google Scholar]
  • 35.Ibler KS, Jemec GB, Flyvholm MA, Diepgen TL, Jensen A, Agner T. Hand eczema: prevalence and risk factors of hand eczema in a population of 2274 healthcare workers. Contact Dermatitis. 2012;67(4):200–7. Epub 2012/05/26. 10.1111/j.1600-0536.2012.02105.x . [DOI] [PubMed] [Google Scholar]
  • 36.Cvetkovski RS, Rothman KJ, Olsen J, Mathiesen B, Iversen L, Johansen JD, et al. Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. The British journal of dermatology. 2005;152(1):93–8. Epub 2005/01/20. 10.1111/j.1365-2133.2005.06415.x . [DOI] [PubMed] [Google Scholar]
  • 37.Kupiszewki M, Illeries S, Durham H, Rees P. Internal Migration and Regional Population Dynamics in Europe: Denmark Case Study. 2001;1. [Google Scholar]
  • 38.Schram ME, Tedja AM, Spijker R, Bos JD, Williams HC, Spuls PI. Is there a rural/urban gradient in the prevalence of eczema? A systematic review. The British journal of dermatology. 2010;162(5):964–73. Epub 2010/03/25. 10.1111/j.1365-2133.2010.09689.x . [DOI] [PubMed] [Google Scholar]
  • 39.Bonamonte D, Filoni A, Vestita M, Romita P, Foti C, Angelini G. The Role of the Environmental Risk Factors in the Pathogenesis and Clinical Outcome of Atopic Dermatitis. BioMed research international. 2019;2019:2450605. Epub 2019/05/24. 10.1155/2019/2450605 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Shram MJ, Quinn AM, Chen N, Faulknor J, Luong D, Sellers EM, et al. Differences in the In Vitro and In Vivo Pharmacokinetic Profiles of Once-Daily Modified-Release Methylphenidate Formulations in Canada: Examination of Current Bioequivalence Criteria. Clin Ther. 2012;34(5):1170–81. 10.1016/j.clinthera.2012.02.010 [DOI] [PubMed] [Google Scholar]
  • 41.Shahar S, Vanoh D, Mat Ludin AF, Singh DKA, Hamid TA. Factors associated with poor socioeconomic status among Malaysian older adults: an analysis according to urban and rural settings. BMC Public Health. 2019;19(Suppl 4):549–. 10.1186/s12889-019-6866-2 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kubota K, Machida I, Tamura K, Take H, Kurabayashi H, Akiba T, et al. Treatment of refractory cases of atopic dermatitis with acidic hot-spring bathing. Acta dermato-venereologica. 1997;77(6):452–4. Epub 1997/12/12. 10.2340/0001555577452454 . [DOI] [PubMed] [Google Scholar]
  • 43.Djurhuus S, Hansen HS, Aadahl M, Glümer C. The association between access to public transportation and self-reported active commuting. Int J Environ Res Public Health. 2014;11(12):12632–51. Epub 2014/12/10. 10.3390/ijerph111212632 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Feroze Kaliyadan

21 Apr 2021

PONE-D-20-40974

The association between water hardness and xerosis – results from the Danish Blood Donor Study

PLOS ONE

Dear Dr. Henning,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Feroze Kaliyadan, M.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

3. In your statistical analyses, please state whether you accounted for clustering by locality/ municipality. For example, did you consider using multilevel models?

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. Thank you for stating the following in the Competing Interests section:

'I have read the journal's policy and the authors of this manuscript have the following competing interests:

Dr. Henning reports grants from Leo Foundation, Denmark (number LF 18002), during the conduct of the study. Dr. Ibler has nothing to disclose. Dr. Ullum has nothing to disclose. Dr. Erikstrup has nothing to disclose. Dr. Bruun has nothing to disclose. Dr. Burgdorf has nothing to disclose. Dr. Dinh has nothing to disclose. Dr. Rigas has nothing to disclose. Dr. Thørner has nothing to disclose. Dr. Pedersen has nothing to disclose. Dr. Jemec reports grants and personal fees from Abbvie, personal fees from Coloplast, personal fees from Chemocentryx, personal fees from LEO pharma, grants from LEO Foundation, grants from Afyx, personal fees from Incyte, grants and personal fees from InflaRx, grants from Janssen-Cilag, grants and personal fees from Novartis, grants and personal fees from UCB, grants from CSL Behring, grants from Regeneron, grants from Sanofi, personal fees from Kymera, personal fees from VielaBio, outside the submitted work.'

a. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these.

Please note that we cannot proceed with consideration of your article until this information has been declared.

b. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

Additional Editor Comments:

Please recheck the reference format thoroughly for all references.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Review Comments to the Author

Reviewer #1: The article is well-written, the language is appropriate and the topic is remarkable. This paper estimates the prevalence of xerosis in blood donors, evaluating some co-variables such as water hardness, sex, age and smoking. I think it could be accepted with minor revisions.

In the introduction section (line 61 e 65), you affirmed that xerosis is one the most important symptoms of dermatoses, including dermatitis. “Dermatitis” is a generic term which can include several cutaneous skin disorders such as atopic dermatitis, allergic/ irritant contact dermatitis and other inflammatory disorders. Could you be more specific?

In the “participants with xerosis” section (line 100), you excluded patients with ichthyosis, lichen planus and psoriasis from Xerosis 1 group and patients with dermatitis from xerosis group 2. What do you mean with the term “ dermatitis”? What about patients with atopic dermatitis? Are you using the term “dermatitis” as synonymous of atopic dermatitis?

Xerosis is only a self-reposted symptom. Maybe, it could be useful the evaluation of xerosis, using biophysical skin parameters, such as TEWL (trans-epidermal water loss) and corneometry.

The study is well-conducted and statistical analysis is accurate. In my opinion, there is one important bias, which is the choice of study population. The blood donors are healthy and young subjects with no co-morbidities. This fact could influence the prevalence of xerosis, being not representative of all Danish population.

Reviewer #2: This is an interesting study evaluating the water hardness and xerosis using a cohort of probably healthy adults who donated blood in Denmark. This is of importance as there have been increasing interest in how environmental factors might affect skin barrier function as well as chronic inflammatory skin conditions.

Introduction

The authors provided a good introduction and provided a good context in Denmark to allow readers to appreciate how the water system is like in Denmark.

Methods.

Authors have divided their analysis into cases 1 and controls 1 as well as cases 2 and controls 2. However, they have not explained the rationale clearly in this segregation.

It is also unknown why the authors have specifically excluded skin conditions such as ichthyosis , lichen planus and psoriasis when there are several conditions that might be similar (also causing xerosis). It is important that the authors explain the rationale to avoid appearing to be cherry picking.

Correcting for multiple testing may not be necessary if authors are looking at a single pre-defined outcomes. In this instance, there are several confounders but one clear outcome.

Discussion

It is important for the authors to provide some information on how is the study participant’s home municipality determined. Is it from census data and how accurate would this data be? Would participants be usually work and live in the same municipality. This would critically affect the data analysis itself.

Finally, the authors should perhaps discussed the threat of possible ecological bias. Authors did mentioned and offer suggestions that other local environmental factors might be responsible other than water hardness.

Other comments:

I am curious why have the authors not choose atopic eczema, or dermatitis as one of its outcome as primary analysis or as sensitivity analysis. Eczema is a known chronic skin condition with epidermal barrier dysfunction. Self reported eczema or those with diagnosis codes as eczema should be included as cases and controls as be included to assess the relationship.

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jun 2;16(6):e0252462. doi: 10.1371/journal.pone.0252462.r002

Author response to Decision Letter 0


27 Apr 2021

Dear Editors and Reviewers,

Thank you for these highly appreciated comments. We firmly believe, that by addressing your comments, the quality of this manuscript has improved considerably. Below, you will find our point-by-point response to each comment.

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response 1:

Thank you for this comments. The manuscript has been updated according to the instructions provided above by PLOS ONE.

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response 2:

We have reviewed the reference list and eliminated reference number 39 “Alfvén T, Braun-Fahrländer C, Brunekreef B, von Mutius E, Riedler J, Scheynius A, et al. Allergic diseases and atopic sensitization in children related to farming and anthroposophic lifestyle--the PARSIFAL study. Allergy. 2006;61(4):414-21. Epub 2006/03/04. doi: 10.1111/j.1398-9995.2005.00939.x. PubMed PMID: 16512802” and added “Schram ME, Tedja AM, Spijker R, Bos JD, Williams HC, Spuls PI. Is there a rural/urban gradient in the prevalence of eczema? A systematic review. The British journal of dermatology. 2010;162(5):964-73. Epub 2010/03/25. doi: 10.1111/j.1365-2133.2010.09689.x. PubMed PMID: 20331459.” In its place. This was done because Alfvén et al. provided information that already was mentioned in the refrence by Schram et al., which was already part of the manuscript.

It should noted that we have added a reference by Schmidt et al. (reference number 14), as it provides essential information on Danish registries that we used in response to a highly relevant comment by Reviewer 2. For further information, please see under Response 13 below. Likewise, we added a refernce by Djurhuus et al. (reference numbe 43) to provide a reponse to Reviewer 2. See Response 14.

3. In your statistical analyses, please state whether you accounted for clustering by locality/ municipality. For example, did you consider using multilevel models?

Response 3:

Thank you for this most relevant comment. We did not account for clustering by locality/municipality because the water hardness data was presented on municipality level and therefore, accounting for municipality would likely have led to over-adjustment bias. However, we did adjust for socio-economic status to adjust for living in urbanized zones. This is addressed as follows: “The statistical analysis did not account for clustering by municipality.” On page 9, lines 175-176.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Response 4:

The data of this study and are only available upon request due to legal restrictions imposed by the Danish Act on Processing of Personal Data on sharing data publicly. This have accordingly been updated as follows: “Data cannot be shared publicly because of legal restrictions imposed by the Danish Act on Processing of Personal Data. Data are available from the Videncenter for Dataanmeldelser (contact via webpage: https://www.regionh.dk/til-fagfolk/Forskning-og-innovation/jura-og-data/Videnscenterfordataanmeldelser/Sider/default.aspx; telephone number +45 29 35 67 99; and e-mail: cru-fp-vfd@regionh.dk) for researchers who meet the criteria for access to confidential data.” on page 9, lines 181-186.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Response:

We have addressed a) and b) in a separate Revised Cover letter.

5. Thank you for stating the following in the Competing Interests section:

'I have read the journal's policy and the authors of this manuscript have the following competing interests:

Dr. Henning reports grants from Leo Foundation, Denmark (number LF 18002), during the conduct of the study. Dr. Ibler has nothing to disclose. Dr. Ullum has nothing to disclose. Dr. Erikstrup has nothing to disclose. Dr. Bruun has nothing to disclose. Dr. Burgdorf has nothing to disclose. Dr. Dinh has nothing to disclose. Dr. Rigas has nothing to disclose. Dr. Thørner has nothing to disclose. Dr. Pedersen has nothing to disclose. Dr. Jemec reports grants and personal fees from Abbvie, personal fees from Coloplast, personal fees from Chemocentryx, personal fees from LEO pharma, grants from LEO Foundation, grants from Afyx, personal fees from Incyte, grants and personal fees from InflaRx, grants from Janssen-Cilag, grants and personal fees from Novartis, grants and personal fees from UCB, grants from CSL Behring, grants from Regeneron, grants from Sanofi, personal fees from Kymera, personal fees from VielaBio, outside the submitted work.'

a. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these.

Please note that we cannot proceed with consideration of your article until this information has been declared.

Response 5a:

Thank for you for making us aware of this. This section has been added.

b. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

Response 5b:

Thank for you for making us aware of this. An updated Competing Interests statement has been added in the Revised Cover Letter.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

Additional Editor Comments:

Please recheck the reference format thoroughly for all references.

Response 6:

We have rechecked the reference format for all references. The reference number 22, which is to a webpage, has been updated.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Review Comments to the Author

Reviewer #1: The article is well-written, the language is appropriate and the topic is remarkable. This paper estimates the prevalence of xerosis in blood donors, evaluating some co-variables such as water hardness, sex, age and smoking. I think it could be accepted with minor revisions.

In the introduction section (line 61 e 65), you affirmed that xerosis is one the most important symptoms of dermatoses, including dermatitis. “Dermatitis” is a generic term which can include several cutaneous skin disorders such as atopic dermatitis, allergic/ irritant contact dermatitis and other inflammatory disorders. Could you be more specific?

Response 7:

Thank you for addressing this point. As we mean atopic dermatitis, we have updated the sentence to the following: “In severe forms, xerosis can be a cardinal symptom of several dermatoses, including atopic dermatitis (AD), ichthyosis and psoriasis” on page 4, lines 52-53.

In the “participants with xerosis” section (line 100), you excluded patients with ichthyosis, lichen planus and psoriasis from Xerosis 1 group and patients with dermatitis from xerosis group 2. What do you mean with the term “ dermatitis”? What about patients with atopic dermatitis? Are you using the term “dermatitis” as synonymous of atopic dermatitis?

Xerosis is only a self-reposted symptom. Maybe, it could be useful the evaluation of xerosis, using biophysical skin parameters, such as TEWL (trans-epidermal water loss) and corneometry.

Response 8:

Thank you for making us aware of this very important point. Dermatitis is defined according to self-reported symptoms of hand eczema and atopic dermatitis and according to ICD-10 codes including the chapters for atopic dermatitis (L20), seborrheic dermatitis (L21), diaper dermatitis (L22), allergic contact dermatitis (L23), irritant contact dermatitis (L24), unspecified contact dermatitis (L25), exfoliative dermatitis (L26) and other dermatitis (L30). The exact items defining self-reported hand eczema and atopic dermatitis are presented in the section titles “Dermatitis, Ichthyosis, Lichen Planus and Psoriasis” on page 6-7, lines 111-120. The ICD-10 codes are presented in S1 Table. However, to further the understanding of how we defined dermatitis, we have added the following section “a history of atopic dermatitis, seborrheic dermatitis, diaper dermatitis, allergic contact dermatitis, irritant contact dermatitis, unspecified contact dermatitis, exfoliative dermatitis or hand eczema” on page 6, lines 96-98.

We highly value your suggestions with biophysical skin parameters (TEWL and corneometry) and agree with its utility in diagnosing xerosis. However, as this is a registry-based study, we did not have the opportunity to examine the participants with such methods.

The study is well-conducted and statistical analysis is accurate. In my opinion, there is one important bias, which is the choice of study population. The blood donors are healthy and young subjects with no co-morbidities. This fact could influence the prevalence of xerosis, being not representative of all Danish population.

Response 9:

Thank you for providing us this this most insightful comment. Blood donors are indeed healthier than non-blood donors due to blood donation criteria that must be meet by blood donors. This likely reduced the prevalence of xerosis in this study population as individuals with diseases or under medication that can cause xerosis were not allowed to donate blood. In order to highlight this very important point, we have altered a sentence on page 18, lines 243-244, as follows: “The healthy donor effect, i.e. the lower proportion of morbidity in blood donors than in the background population, likely reduced the prevalence of xerosis in the study population as compared to the prevalence of xerosis in the Danish population.”

Reviewer #2: This is an interesting study evaluating the water hardness and xerosis using a cohort of probably healthy adults who donated blood in Denmark. This is of importance as there have been increasing interest in how environmental factors might affect skin barrier function as well as chronic inflammatory skin conditions.

Introduction

The authors provided a good introduction and provided a good context in Denmark to allow readers to appreciate how the water system is like in Denmark.

Methods.

Authors have divided their analysis into cases 1 and controls 1 as well as cases 2 and controls 2. However, they have not explained the rationale clearly in this segregation.

Response 10:

The intention was to isolate individuals with xerosis not caused by concurrent diseases. This was achieved by including blood donors, who have none-to-few systemic diseases or take medications that can lead to xerosis. Additionally, we excluded individuals with ichthyosis, lichen planus and psoriasis to define xerosis 1, as these dermatoses can manifest with dry skin. Lastly, we excluded anyone with different kinds of dermatitis to define xerosis 2.

The reason for this division between xerosis 1 and xerosis 2, i.e., the additional exclusion of dermatitis, was because in the clinical context, the transition from dry skin, as in xerosis, to different kinds of dermatitis is not always clear. Conversely, mild dermatitis can clinically be defined by presence of only xerosis. First, to avoid eliminating potential cases of xerosis, we chose to define xerosis 1 with dermatitis, Then, to identify the most homogenous group that only had xerosis without any moderate or severe degree of dermatitis, we chose to define xerosis 2.

This is addressed in the following section: “To isolate xerosis, concurrent disease that can cause xerosis was excluded. This was done by including blood donors who have few systemic diseases or who are under chronic medication that can cause xerosis. Additionally, we excluded anyone with dermatoses that are known to manifest with xerosis, such as ichthyosis, lichen planus, psoriasis and dermatitis. In the clinical context, the transition from dermatitis to xerosis is not always clear. Conversely, mild dermatitis can manifest only with xerosis. Therefore, to avoid eliminating potential cases with xerosis we chose to first define a study population with dermatitis (i.e. xerosis 1) and then also define a homogenous population with xerosis without moderate or severe dermatitis (i.e. xerosis 2).” See page 8, lines 148-156.

It is also unknown why the authors have specifically excluded skin conditions such as ichthyosis, lichen planus and psoriasis when there are several conditions that might be similar (also causing xerosis). It is important that the authors explain the rationale to avoid appearing to be cherry picking.

Response:11

Thank you for this most important comment. We take the liberty of referring you to Response 10 to answer this valid point.

Correcting for multiple testing may not be necessary if authors are looking at a single pre-defined outcomes. In this instance, there are several confounders but one clear outcome.

Response 12:

Thank you for this most relevant point. In Table 3, the non-corrected p-values are presented while superscript b indicates whether the association between the predictor and the outcome was significant after correcting for multiple testing. Therefore, we believe this approach provides a relevant level of information that allows the reader to determine for themselves if they deem the uncorrected or corrected p-values most relevant.

Discussion

It is important for the authors to provide some information on how is the study participant’s home municipality determined. Is it from census data and how accurate would this data be?

Response 13:

Thank you for this highly important question. In Denmark, since 1968 all citizens are upon birth assigned a unique Civil Personal Register (CPR) Number. The CPR number enables efficient linking of databases and complete and accurate registration of data including the home address, hospital records and other records used in this study. This ensures that data on for instance home addresses is 100% accurate. To describe this, we have added the section: “Danish citizens born after 1967 are assigned a unique Civil Personal Register (CPR) Number. This ensures efficient linking of different databases and complete and accurate registration of data, including home addresses and hospital diagnoses, which were used in this study.” On page 5, lines 88-91. We have also added a reference that describes this matter by Schmidt et al. You can also find more information on: https://econ.au.dk/the-national-centre-for-register-based-research/danish-registers/the-danish-civil-registration-system-cpr/

Would participants be usually work and live in the same municipality. This would critically affect the data analysis itself.

Response 14:

Thank you for this most valuable comment. It remains uncertain whether people live and work in the same municipalities. This is a potential bias as some jobs are exposed to water routinely. However, the level of water hardness is generally the same across several neighboring municipalities, which means that individuals who work and live in neighboring municipalities are exposed to the same level of water hardness. Additionally, many jobs does not include ‘wet work’. Therefore, we argue that the home municipality is the best approximation for routine water exposure. To further describe this potential source of bias, we have added the following: “Another potential bias is that some study participants may have been working in areas other than their home municipality, and thereby been exposed to different levels of water hardness. However, the level of water hardness is generally the same across several neighboring municipalities, which means that working in neighboring municipalities would not necessarily change the water hardness exposure. This is further substantiated by a study of almost 29,000 Danes that showed that the mean distance of commute to work or education was 14.6 km, which implies that many work in their home or neighboring municipalities. Additionally, many jobs do not include ‘wet work’. Therefore, we argue that the home municipality is the best approximation for routine water exposure”. See page 22, lines 337-345. We have also added a reference to support this.

Finally, the authors should perhaps discussed the threat of possible ecological bias. Authors did mentioned and offer suggestions that other local environmental factors might be responsible other than water hardness.

Response 15:

Thank you for this comment. We are not quite sure what you refer to with ‘ecological bias’ in this context. If you mean ecological fallacy (i.e. the interpretation of data where inference about the nature of individuals is deduced from inference for the group to which those individuals belong), we firmly agree with you. We cannot with certainty know that each individual exposed to ‘Hard water’ is destined to develop xerosis, or conversely that individuals exposed to ‘Soft water” never develops xerosis, which also is reported in Table 1. However, the odds ratio suggest an increased and decreased risk of developing xerosis depending on whether the study participant live in areas with hard or soft water, respectively. We believe that by reporting the results as odds ratios with 95% confidence intervals, we convey a message that reflects this. Consequently, with all due respect, we believe that the ecologic fallacy is adequately addressed in the manuscript. Therefore, and also because we are not sure what you mean by ‘ecological bias’, we have chosen not to add any additional text to the manuscript. However, please let us know if you find this response inadequate or insufficient, and we would be happy to meet your suggestions.

Other comments:

I am curious why have the authors not choose atopic eczema, or dermatitis as one of its outcome as primary analysis or as sensitivity analysis. Eczema is a known chronic skin condition with epidermal barrier dysfunction. Self reported eczema or those with diagnosis codes as eczema should be included as cases and controls as be included to assess the relationship.

Response 16:

Thank you for this most relevant comment. The reason for investigating xerosis is that previous studies have shown that ‘hard water’ is associated with atopic dermatitis, mostly in children and teenagers. As atopic dermatitis is a composition of various symptoms, including xerosis, we were wondering if isolated xerosis may be the constituent of dermatitis that mediates the previously reported association with atopic dermatitis. As this results indeed indicate that xerosis is associated with water hardness, this implies that, at least in part, the association between water hardness and atopic dermatitis may be mediated by an association between water hardness and xerosis.

By determining whether the case population with dermatitis (‘Xerosis 1’ and ‘Controls 1’) and without dermatitis (‘Xerosis 2’ and ‘Controls 2’) were associated with xerosis, we conducted a sensitivity analysis.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Feroze Kaliyadan

17 May 2021

The association between water hardness and xerosis – results from the Danish Blood Donor Study

PONE-D-20-40974R1

Dear Dr. Henning,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Feroze Kaliyadan, M.D.

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for your response. Unfortunately this manuscript is only a registry-based study and the authors did not have the opportunity to examine other cutaneous paramethers for skin barrier dysfunction. However, the article could be accepted because it can be a useful tools for further manuscripts about the same topics.

Reviewer #2: Thank you for your response.

All comments have been sufficiently addressed.

And yes I was referring to ecological fallacy in my earlier comment.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Feroze Kaliyadan

21 May 2021

PONE-D-20-40974R1

The association between water hardness and xerosis – results from the Danish Blood Donor Study

Dear Dr. Henning:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Feroze Kaliyadan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Forest plot of adjusted multinominal regression.

    (TIFF)

    S1 Table. ICD-10th diagnoses used to define xerosis, dermatitis, ichthyosis, lichen planus and psoriasis.

    (DOCX)

    S2 Table. Adjusted multivariable nominal regression with xerosis as outcome.

    (DOCX)

    S3 Table. Multivariable nominal regression with xerosis as outcome and interaction for age and sex.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    Data cannot be shared publicly because of legal restrictions imposed by the Danish Act on Processing of Personal Data. Data are available from the Videncenter for Dataanmeldelser (contact via webpage: https://www.regionh.dk/til-fagfolk/Forskning-og-innovation/jura-og-data/Videnscenterfordataanmeldelser/Sider/default.aspx; telephone number +45 29 35 67 99; and e-mail: cru-fp-vfd@regionh.dk) for researchers who meet the criteria for access to confidential data.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES